Guru Ownership Trend
Guru Analysis for Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. (NAUT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $683,744.48.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $766,155.73 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 159.9%. Conversely, Steven Cohen reduced exposure by 18.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Nautilus Biotechnology, Inc. (NAUT)
Major holders include Renaissance Technologies (RenTech) ($1.29 M), Steven Cohen ($127,044). According to the latest reported data, 2 tracked investment managers collectively hold approximately 758,452 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $766,155.73, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited NAUT. The total reported sell value was $28,246.34.
Yes, 0 managers opened new positions in NAUT, and 1 increased their existing holdings. The total reported buy value was $794,402.07.